You have 9 free searches left this month | for more free features.

Pegaspargase

Showing 26 - 50 of 149

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Drug/Agent Toxicity by Tissue/Organ, Leukemia Trial in Canada, Puerto Rico, United States (asparaginase, cyclophosphamide,

Completed
  • Drug/Agent Toxicity by Tissue/Organ
  • Leukemia
  • Boston, Massachusetts
  • +9 more
Nov 9, 2022

Extranodal NK/T-cell Lymphoma Trial (Basiliximab, Pegaspargase)

Unknown status
  • Extranodal NK/T-cell Lymphoma
  • (no location specified)
Apr 6, 2020

Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type Trial in Guangzhou (pegaspargase, Gemcitabine, Oxaliplatin)

Recruiting
  • Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type
  • pegaspargase
  • +5 more
  • Guangzhou, Guangdong, China
    Department of Medical Oncology, Sun Yat-sen University Cancer Ce
Mar 12, 2021

Lymphoma, Lymphoblastic Trial in GuangZhou (induction phase1, induction phase2, protocol M)

Unknown status
  • Lymphoma, Lymphoblastic
  • induction phase1
  • +6 more
  • GuangZhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Aug 31, 2020

Treatment Refusal Trial in Guangzhou (Gemcitabine, etoposide, Pegaspargase)

Unknown status
  • Treatment Refusal
  • Guangzhou, Please Select, China
    Sun Yat-sen University Cancer Center
Dec 16, 2020

Acute Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma Trial in Australia, United States (Prednisone, Vincristine,

Recruiting
  • Acute Lymphoblastic Leukemia
  • Acute Lymphoblastic Lymphoma
  • Palo Alto, California
  • +6 more
May 2, 2022

T Acute Lymphoblastic Leukemia, T Lymphoblastic Lymphoma Trial in Houston (Cyclophosphamide, Cytarabine, Dexamethasone)

Recruiting
  • T Acute Lymphoblastic Leukemia
  • T Lymphoblastic Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Jan 11, 2023

Extranodal NK-T-Cell Lymphoma, Nasal Type Trial in Shanghai, Urumqi (MEDA, Auto-HSCT)

Completed
  • Extranodal NK-T-Cell Lymphoma, Nasal Type
  • Shanghai, Shanghai, China
  • +6 more
Apr 24, 2020

Leukemia, Acute Lymphoblastic Leukemia Trial in Houston (Rituximab, Cyclophosphamide (CTX), Doxorubicin)

Completed
  • Leukemia
  • Acute Lymphoblastic Leukemia
  • Houston, Texas
    UT MD Anderson Cancer Center
Dec 1, 2020

NK/T Cell Lymphoma Nos Trial in Beijing (Sintilimab, Lenalidomide)

Unknown status
  • NK/T Cell Lymphoma Nos
  • Beijing, China
    Beijing Tongren Hospital
May 6, 2020

B Acute Lymphoblastic Leukemia, Ph-Like Acute Lymphoblastic Leukemia Trial in Duarte (Cyclophosphamide, Cytarabine, Daunorubicin

Recruiting
  • B Acute Lymphoblastic Leukemia
  • Ph-Like Acute Lymphoblastic Leukemia
  • Duarte, California
    City of Hope Medical Center
Jul 26, 2022

Acute Lymphoblastic Leukemia Trial in Canada, United States (ITMHA, Dexamethasone, Mitoxantrone)

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • Los Angeles, California
  • +17 more
Jun 6, 2022

Leukemia, Lymphocytic, Lymphoblastic Lymphoma, T-cell Lymphoma Trial in United States (Palbociclib, Cytarabine, Methotrexate)

Active, not recruiting
  • Leukemia, Lymphocytic
  • +5 more
  • Birmingham, Alabama
  • +18 more
Feb 25, 2022

Acute Lymphoblastic Leukemia Trial in GuangZhou (Cladribine, G-CSF, Cytarabine)

Unknown status
  • Acute Lymphoblastic Leukemia
  • GuangZhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Aug 18, 2019

Lymphoma Trial in Changsha (pegaspargase, Gemcitabine, Oxaliplatin)

Unknown status
  • Lymphoma
  • pegaspargase
  • +8 more
  • Changsha, Hunan, China
    Hunan Cancer Hospital
Jan 25, 2020

Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Canada, United States (asparaginase Erwinia chrysanthemi)

Completed
  • Acute Lymphoblastic Leukemia
  • Lymphoblastic Lymphoma
  • asparaginase Erwinia chrysanthemi
  • Los Angeles, California
  • +21 more
Jun 1, 2021

Acute Lymphoblastic Leukemia, Pediatric Trial in Worldwide (Blinatumomab, Bortezomib, Cyclophosphamide)

Recruiting
  • Acute Lymphoblastic Leukemia, Pediatric
  • Sydney, Australia
  • +114 more
Nov 1, 2022

Recurrent B Acute Lymphoblastic Leukemia, Recurrent T Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia

Recruiting
  • Recurrent B Acute Lymphoblastic Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 2, 2022

Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Mixed Phenotype Acute Leukemia

Not yet recruiting
  • Recurrent Acute Leukemia of Ambiguous Lineage
  • +5 more
  • Biospecimen Collection
  • +12 more
  • (no location specified)
Mar 8, 2023

B Acute Lymphoblastic Leukemia Trial (procedure, biological, drug, radiation)

Not yet recruiting
  • B Acute Lymphoblastic Leukemia
  • Biospecimen Collection
  • +19 more
  • (no location specified)
Nov 8, 2023

B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma, Down Syndrome Trial in Worldwide (drug, biological, radiation)

Recruiting
  • B Acute Lymphoblastic Leukemia
  • +2 more
  • Asparaginase Erwinia chrysanthemi
  • +15 more
  • Birmingham, Alabama
  • +219 more
Aug 24, 2022

Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia Trial in Worldwide

Active, not recruiting
  • Acute Leukemia of Ambiguous Lineage
  • +2 more
  • Birmingham, Alabama
  • +173 more
Nov 16, 2021

Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia, Childhood B Acute Lymphoblastic Leukemia Trial in United

Completed
  • Acute Lymphoblastic Leukemia
  • +2 more
  • Calaspargase Pegol-mknl
  • +14 more
  • Birmingham, Alabama
  • +26 more
Apr 2, 2021

ALL, Childhood, Lymphoblastic Lymphoma, Childhood, Lymphoblastic Leukemia, Acute, Childhood Trial in Australia, United States

Recruiting
  • ALL, Childhood
  • +2 more
  • Los Angeles, California
  • +17 more
Aug 11, 2022